- +91 9540004683Team Member
- New Rajinder Nagar, New DelhiCorporate Office Location
- 09:30AM - 06:00PMOffice Timing
Amendment in Export Policy of Enoxaparin (formulation and ApI) and Intra-Venous Immunoglobulin(IVIG)(Formuation and API)-regarding
(To be Published in the Gazette of India Extraordinary Part-II Section-3, Sub-Setion(ii))
Government of India
Ministry of Commerce & Industry
Department of Commerce
Directorate General of Foreign Trade
Udyog Bhawan, New Delhi-110011
Notification No.50/2015-2020
New Delhi Date:10 January, 2022
Subject: Amendment in Export Policy of Enoxaparin (formulation and ApI) and Intra-Venous Immunoglobulin(IVIG)(Formuation and API)-regarding
S.O(E) In exercise of power conferred by Section 3 read with Section 5 of the Foreign Trade (Development & Regulation) Act,1992(No.22 of 1992), as amended read with Para 1.02 and 2.01 of the Foreign Trade Policy,2015-20, the Central Government hereby makes the following amendment in chapter 29 and 30 of Schedule 2 of the ITCHS Export policy 2018 related to export of Enoxaparin and Intra-Venous Immunogobulin (IVIG):
S.No:- 207AE
ITC HS Codes:- EX2942 | Ex3001 | Ex3002
Description:- Enoxaparin (Formulation and API)
Present Policy:- Free
Revised Policy:- Restricted
S.No:- 207AF
ITC HS Codes:- Ex3002
Description:- Intra -Venous Immunoglobulin (IVIG) (Formulation and API)
Present Policy:- Free
Revised Policy:- Restricted
2:- Effect of this Notification
The export of Enoxaparin ( formulation and API) and Intra-Venous Immunoglobulin (IVIG) Fomulation and API)falling under the ITC (HS) Code specified above or falling under any other HS Code has been put under restricted category, with immediate effect.
(Issued from File No. 01/91/180/021/AM22/EC/E-30431)
Team Edu-visor